Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

EULAR 2014: Collaboration Among Rheumatology Groups Expected to Build

Thomas R. Collins  |  Issue: September 2014  |  September 1, 2014

PARIS, FRANCE—The amount of collaboration between the American College of Rheumatology and the European League Against Rheumatism, as well as other international groups, is likely to continue to grow when it comes to creating criteria and response sets, and patient management guidelines, said Kenneth Saag, MD, MSc, professor of medicine at the University of Alabama at Birmingham, a member of the ACR Board of Directors, and a leader in the writing of the ACR’s most recent RA management guidelines.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

There are hurdles to overcome, however, not the least of which is the different healthcare systems involved, Dr. Saag said in a session on RA management guidelines throughout the world at the Annual European Congress of Rheumatology (EULAR 2014) in June. His talk also delved into the philosophy behind guideline creation and touched on future additions to ACR guidelines.

As for international cooperation, ACR and EULAR have already collaborated on remission criteria, and they jointly developed classification criteria on polymyalgia rheumatica (PMR), which were presented this year at another EULAR session.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Saag said the presentation of the PMR guidelines made it a “pivotal meeting” for joint guideline efforts.

Dr. Smolen
Dr. Smolen

“It’s also important to highlight that the joint activity between ACR and EULAR along classification response criteria has been ongoing quite successfully for many years,” he said.

He said he’d like more collaboration not just with EULAR but other large, international organizations, too. But with such factors as “institutional politics,” it can be a “complicated” endeavor.

“Trying to just maintain the flow with EULAR is challenging for both sides—to deal with financial models, to deal with conflict issues, to deal with different healthcare systems,” he said. “And that’s where I think it’s been a little more challenging for guidelines. But it doesn’t mean we can’t do it, and in fact we have momentum. This is a positive sign.”

Dr. Saag
Dr. Saag

Early Days

Josef Smolen, MD, chair of the Division of Rheumatology at the Medical University of Vienna, said it was worth remembering that efforts at collaborating are only 10 years old. He said it was 2003 when he suggested that the ACR and EULAR start working together.

“It took a few years to get it off the ground,” he said. “And I find it fantastic that we already have so many common activities. And not only activities, but results.”

He acknowledged the difficulties.

“We in Europe cannot understand that something that [we’ve had for] 120 years is only being debated in the United States,” he said. “So there are these differences in healthcare systems.”

Constant Change

In his remarks about the ACR guidelines, Dr. Saag described a constant state of reexamination—evidence changes or emerges and methods of creating the guidelines change, leading to adaptations that are always attempting to keep pace with the medicine.

Page: 1 2 3 | Single Page
Share: 

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug UpdatesEULAR/OtherMeeting Reports Tagged with:AC&RAmerican College of Rheumatology (ACR)BiologicscollaborationCollinsdrugEULARGlucocorticoidsInternationalpatient carePolymyalgia RheumaticarheumatologySafetyTofacitinib

Related Articles

    TNF Blockade for SLE

    September 1, 2010

    Reckless approach versus missed opportunity?

    ACR Publishes New Guide for RA Care

    July 1, 2008

    Updated guidelines synthesize and formalize recommendations for DMARD use

    racorn/shutterstock.com

    EULAR Releases 2016 Recommendations on RA Management

    July 14, 2017

    Management of rheumatoid arthritis (RA) is complex. The ever-expanding availability of new drugs requires that rheumatologists and patients constantly consider treatment strategies and targets aimed at both disease control and symptom relief while remaining cognizant of the increasing high cost of emerging medications. Given such complexity, guidelines to inform rheumatologists about the most recent developments…

    The Why & What of the ACR's Clinical Practice Guidelines

    The Why & What of the ACR’s Clinical Practice Guidelines

    February 18, 2018

    With the support of its membership, the ACR publishes clinical practice guidelines in multiple disease areas based on the best available clinical and scientific data. These aim to support health professionals treating rheumatology patients to give the best possible care. Like any set of medical guidelines, ACR guidelines are based on evidence of several different…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences